Fresenius Medical Care AG & Co. KGaA (FME) Given a €87.00 Price Target by HSBC Analysts

HSBC set a €87.00 ($101.16) price target on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research note issued to investors on Tuesday. The firm currently has a buy rating on the stock.

A number of other research firms have also issued reports on FME. Berenberg Bank set a €87.80 ($102.09) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Friday, December 7th. Nord/LB set a €82.00 ($95.35) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Wednesday, February 20th. JPMorgan Chase & Co. set a €83.20 ($96.74) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Thursday, December 20th. Jefferies Financial Group set a €68.00 ($79.07) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a report on Thursday, March 7th. Finally, Kepler Capital Markets set a €76.00 ($88.37) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Thursday, February 21st. Nine analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Fresenius Medical Care AG & Co. KGaA currently has an average rating of Buy and a consensus target price of €82.68 ($96.14).

Fresenius Medical Care AG & Co. KGaA stock opened at €69.68 ($81.02) on Tuesday. The company has a market cap of $21.38 billion and a price-to-earnings ratio of 10.80. Fresenius Medical Care AG & Co. KGaA has a 52-week low of €55.44 ($64.47) and a 52-week high of €91.74 ($106.67). The company has a current ratio of 1.25, a quick ratio of 0.96 and a debt-to-equity ratio of 58.49.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Featured Story: How is the LIBOR rate calculated?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.